POSTER: CML-918: Asciminib in Chronic Myeloid Leukemia in Chronic Phase: Interim Analysis Efficacy and Safety Results of the Phase 2 ASC2ESCALATE Trial in the Cohort of Newly Diagnosed Patients
Moshe Levy, David Andorsky, CelesteAnn Bremer, Joshua Zeidner et autres
0 citationsClinical Lymphoma Myeloma & Leukemia